20 okt: Vælg dine kampe med omhu....og vind dem!
26 okt: Ældre forkæles med rekordpension
24-10-2010 15:31:54

Cooperative mulls life unit disposal

Relateret indhold

LONDON (Reuters) - Britain's Cooperative Group could offload its life insurance arm as it reorganises its financial services division following last year's merger with Britannia, a source familiar with the situation said on Sunday.

Mutually-owned Cooperative, which runs businesses ranging from supermarkets to funeral homes, has appointed Deutsche Bank to review options for the life arm including a possible sale.

The society has sent information packs to potential bidders for the unit, which sells pensions and protection insurance and has 18 billion pounds in assets, in an effort to gauge the level of buyer interest, the source added.

Cooperative and Deutsche Bank both declined to comment.

Potential suitors for the business include listed insurers Legal & General (Legal & General Group PLC), Aviva , Resolution (Resolution Limited ORD NPV) and Phoenix Group, as well as rival customer-owned insurer Royal London, the Mail on Sunday and Sunday Times newspapers reported.

The review of Cooperative's life unit follows the January 2009 merger between its financial services division, which also includes banking, asset management and general insurance operations, and Britannia, the UK's second-biggest building society.

The merger enlarged Cooperative's branch network, and the society wants to sell more products through its bank premises rather than through a direct sales force, currently the main channel for its life insurance products, the Mail on Sunday said.

Britain's life insurance sector has seen a high level of M&A activity this year as major insurers restructure to pursue high-growth markets in Asia, throwing up opportunities for UK-focussed players.

France's Axa sold most of its British business to Resolution for 2.75 billion pounds in June, freeing it up to focus on Asia, while Prudential the previous month narrowly failed to buy AIG's (American International Group) Asian business in what would have been the sector's biggest ever deal.

Aviva and Resolution declined to comment, while L&G, Phoenix Group, and Royal London could not immediately be reached.

(Reporting by Myles Neligan; Editing by David Cowell)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo: Lægemiddelkomité anbefaler godkendelse af Ozempic i Europa - NY2

15-12-2017 13:19:21
Novo Nordisk har fået en vigtig anbefaling fra en lægemiddelkomité under de europæiske sundhedsmyndigheder, EMA, der anbefaler GLP-1-håbet Semaglutid godkendt på det europæiske marked.Semaglutid, der skal markedsføres under navnet Ozempic, skal først officielt godkendes af EMA og EU-Kommissionen, før midlet kan ryge på markedet, men en positiv anbefaling fra lægemiddelkomitéen er som oftest også l..

Aktier/middag: H+H til tops mens C20 går i rødt

15-12-2017 11:41:22
Humøret er vrissent på børserne i Europa fredag, og ved middagstid er det danske C20 Cap-indeks ingen undtagelse, da det falder 0,9 pct. til 1121,34 - især trukket ned af Novo Nordisk.Uden for eliteindekset belønnes H+H International dog pænt for et virksomhedsopkøb til 800 mio. kr., der vil løfte selskabets omsætning med en halv milliard.USA SPREDER DÅRLIG STEMNINGDen generelle nedturen følger i ..

Aktier/tendens: H+H køber sig til hovedrolle fra åbningen

15-12-2017 08:23:48
Et stort opkøb fra H+H International kan få opmærksomhed fra åbningen af det danske aktiemarked fredag, hvor investorerne også skal fordøje en sænket anbefaling af Novo Nordisk.Nyhederne falder i et marked, der meget vel kan falde lidt fra åbningen. I USA lukkede S&P 500-indekset torsdag 0,4 pct. lavere efter at have ligget marginalt positivt ved dansk børslukketid.Nedturen, der også viser sig i e..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Torsdagens aktier: Vestas overstrålede alle i grønt eliteindeks
2
Novo/DZ: Sænker anbefaling til "sælg" fra "hold"
3
Vestas/Senator: Aftale afskærmer stort set også vind fra Beat-skat
4
Genmab/Jyske: Kursmålet trimmes til 1600 kr. - NY
5
Novo: Lægemiddelkomité anbefaler godkendelse af Ozempic i Europa - NY2

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
15. december 2017 17:01:05
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB1 - 2017-12-15 17:01:05 - 2017-12-15 17:01:05 - 1 - Website: OKAY